⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036
globenewswire.com
SNY
REGN
AMGN
AZN
GSK
NVS
TEVA
EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0
globenewswire.com
PFE
MRNA
NVS
MRK
SNY
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
globenewswire.com
SNY
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis
prnewswire.com
SNY
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
globenewswire.com
REGN
SNY
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
globenewswire.com
SNY
REGN
Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
globenewswire.com
SNY
Cardiac Monitoring & Cardiac Rhythm Management Devices Market worth $37.88 billion by 2031 | MarketsandMarkets™
prnewswire.com
GEHC
BSX
BAX
SNY
OSIS
NBDF Launches "Educate to Elevate" Campaign with Celebrity Advocates to Raise Awareness of Bleeding Disorders
prnewswire.com
SNY